Literature DB >> 10392967

A fatty acid binding protein from Fasciola hepatica induced protection in C57/BL mice from challenge infection with Schistosoma bovis.

J L Abán1, V Ramajo, J L Arellano, A Oleaga, G V Hillyer, A Muro.   

Abstract

Three strains of mice (NMRI, C57/BL, BALB/c) were each immunized with a 12 kDa purified, native Fasciola hepatica fatty acid binding protein (Fh12) and challenged percutaneously with Schistosoma bovis cercariae. C57/BL mice immunized with Fh12 had significant reductions in S. bovis worm burden recoveries (96 and 87% reductions over controls in two separate experiments). When using NMRI or BALB/c mice, Fh12 alone or in Freund's adjuvant failed to induce significant protection against S. bovis. In C57/BL mice vaccinated against Fh 12, antibodies to the IgG2a isotype, but not to the IgG1 isotype, increased by 2 weeks after the second immunization and remained high through 8 weeks of S. bovis infection. Antibodies to S. bovis increased after 4 weeks of infection. Regarding cytokine production by spleen mononuclear cells, C57/BL mice vaccinated with Fh12 in adjuvant, and having the highest protective response against challenge infection with S. bovis, had an increase of IFN-gamma production with Concanavalin A but no increase of IL-4 in similarly stimulated cells. These results suggest that the protection obtained in this group of mice is mediated by a Th1 immune response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10392967     DOI: 10.1016/s0304-4017(99)00053-9

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  8 in total

1.  Utility of Schistosoma bovis adult worm antigens for diagnosis of human schistosomiasis by enzyme-linked immunosorbent assay and electroimmunotransfer blot techniques.

Authors:  J Pardo; C Carranza; M C Turrientes; J L Pérez Arellano; R López Vélez; V Ramajo; A Muro
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

2.  Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica-Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family.

Authors:  Daricel Torres; Ana M Espino
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

3.  Effect of lipopolysaccharide (LPS) from Ochrobactrum intermedium on sheep experimentally infected with Fasciola hepatica.

Authors:  J M Martínez-Pérez; D Robles-Pérez; F Valcárcel-Sancho; A M González-Guirado; I Casanova-García de Castro; J M Nieto-Martínez; F A Rojo-Vázquez; M Martínez-Valladares
Journal:  Parasitol Res       Date:  2013-06-06       Impact factor: 2.289

4.  Identification and profiling of circulating antigens by screening with the sera from schistosomiasis japonica patients.

Authors:  Yan Lu; Bin Xu; Chuan Ju; Xiaojin Mo; Shenbo Chen; Zheng Feng; Xiaoning Wang; Wei Hu
Journal:  Parasit Vectors       Date:  2012-06-11       Impact factor: 3.876

5.  Fasciola gigantica fatty acid binding protein (FABP) as a prophylactic agent against Schistosoma mansoni infection in CD1 mice.

Authors:  Ibrahim Rabia Aly; M Diab; A M El-Amir; M Hendawy; S Kadry
Journal:  Korean J Parasitol       Date:  2012-03-06       Impact factor: 1.341

6.  An Efficient Schistosoma japonicum Bivalent Membrane Protein Antigen DNA Vaccine Against Schistosomiasis in Mice.

Authors:  Na Lei; Feng-Chun Liu; Cui-Ping Ren; Ji-Jia Shen; Miao Liu
Journal:  Med Sci Monit       Date:  2019-12-07

7.  The effect of ivermectin alone and in combination with cobicistat or elacridar in experimental Schistosoma mansoni infection in mice.

Authors:  Belén Vicente; Julio López-Abán; Juliane Chaccour; Juan Hernández-Goenaga; Patricia Nicolas; Pedro Fernández-Soto; Antonio Muro; Carlos Chaccour
Journal:  Sci Rep       Date:  2021-02-24       Impact factor: 4.379

8.  Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.

Authors:  Belén Vicente; Julio López-Abán; Jose Rojas-Caraballo; Esther del Olmo; Pedro Fernández-Soto; Antonio Muro
Journal:  Parasit Vectors       Date:  2016-04-18       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.